Results 11 to 20 of about 71,118 (301)

Cholangiocarcinoma [PDF]

Critical Reviews in Oncology/Hematology, 2017
Kolangiokarcinom zloćudni je tumor nastao iz epitela žučnog sustava. Anatomski, dijeli se na intrahepatalni kolangiokarcinom, hilarni kolangiokarcinom i distalni ekstrahepatalni kolangiokarcinom.
Pezdirc, Iskra
core   +3 more sources

Cholangiocarcinoma [PDF]

Pathologica, 2021
Liver cancer represents the third leading cause of cancer-related death worldwide. Cholangiocarcinoma (CCA) is the second most common type of liver cancer after hepatocellular carcinoma, accounting for 10-15% of all primary liver malignancies. Both the incidence and mortality of CCA have been steadily increasing during the last decade.
Sarcognato S., Sacchi D., Fassan M., Fabris L., Cadamuro M., Zanus G., Cataldo I., Capelli P., Baciorri F., Cacciatore M., Guido M.   +10 more
openaire   +7 more sources

Locoregional Treatments in Cholangiocarcinoma and Combined Hepatocellular Cholangiocarcinoma [PDF]

Cancers, 2021
Cholangiocarcinoma (CCA) is a primary and aggressive cancer of the biliary tree. Combined hepatocellular cholangiocarcinoma (CHC) is a distinctive primary liver malignancy which has properties of both hepatocytic and cholangiocytic differentiation.
Matteo Renzulli, Daryl Ramai, Jameel Singh, Samridhi Sinha, Nicolò Brandi, Anna Maria Ierardi, Elisa Albertini, Rodolfo Sacco, Antonio Facciorusso, Rita Golfieri   +9 more
openaire   +4 more sources

The Impact of Pre-analytical Quality Initiatives on Cholangiocarcinoma Diagnostics in Thailand

Frontiers in Public Health, 2022
Cholangiocarcinoma (CCA) is the most prevalent malignancy in Thailand, with unfortunate late diagnosis and frequent metastatic disease outcomes. An accurate tissue diagnosis is the first and most important step in the treatment of CCA. Tissue quality and
Supinda Koonmee, Supinda Koonmee, Supinda Koonmee, Sakkarn Sangkhamanon, Sakkarn Sangkhamanon, Sakkarn Sangkhamanon, Piyapharom Intarawichian, Piyapharom Intarawichian, Piyapharom Intarawichian, Chaiwat Aphivatanasiri, Chaiwat Aphivatanasiri, Chaiwat Aphivatanasiri, Waritta Kunprom, Waritta Kunprom, Waritta Kunprom, Prakasit Sa-ngiamwibool, Prakasit Sa-ngiamwibool, Prakasit Sa-ngiamwibool, Suwit Balthaisong, Suwit Balthaisong, Suwit Balthaisong, Chitsakul Phuyao, Chitsakul Phuyao, Chitsakul Phuyao, Piya Prajumwongs, Piya Prajumwongs, Piya Prajumwongs, Reza Alaghehbandan, Malinee Thanee, Malinee Thanee, Malinee Thanee   +30 more
doaj   +1 more source

Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand

Frontiers in Oncology, 2022
Patients with distal cholangiocarcinoma (dCCA) generally have poor outcomes because of late presentation and diagnosis. Therefore, prognostic factors for predicting outcomes are essential to improve therapeutic strategies and quality of life.
Piyapharom Intarawichian, Piyapharom Intarawichian, Piyapharom Intarawichian, Sirada Sangpaibool, Sirada Sangpaibool, Sirada Sangpaibool, Piya Prajumwongs, Piya Prajumwongs, Piya Prajumwongs, Prakasit Sa-Ngiamwibool, Prakasit Sa-Ngiamwibool, Prakasit Sa-Ngiamwibool, Sakkarn Sangkhamanon, Sakkarn Sangkhamanon, Sakkarn Sangkhamanon, Waritta Kunprom, Waritta Kunprom, Waritta Kunprom, Malinee Thanee, Malinee Thanee, Malinee Thanee, Watcharin Loilome, Watcharin Loilome, Watcharin Loilome, Narong Khuntikeo, Narong Khuntikeo, Narong Khuntikeo, Attapol Titapun, Attapol Titapun, Attapol Titapun, Apiwat Jareanrat, Apiwat Jareanrat, Apiwat Jareanrat, Vasin Thanasukarn, Vasin Thanasukarn, Vasin Thanasukarn, Tharatip Srisuk, Tharatip Srisuk, Tharatip Srisuk, Vor Luvira, Vor Luvira, Vor Luvira, Kulyada Eurboonyanun, Kulyada Eurboonyanun, Kulyada Eurboonyanun, Julaluck Promsorn, Julaluck Promsorn, Julaluck Promsorn, Supinda Koonmee, Supinda Koonmee, Supinda Koonmee, Aileen Wee, Chaiwat Aphivatanasiri, Chaiwat Aphivatanasiri, Chaiwat Aphivatanasiri   +54 more
doaj   +1 more source

Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma

Diagnostics, 2021
The analysis of cfDNA has been applied as a liquid biopsy in several malignancies. However, its value in the diagnosis and prognosis of cholangiocarcinoma (CCA) have not been well defined.
Preawwalee Wintachai, Jing Quan Lim, Anchalee Techasen, Worachart Lert-itthiporn, Sarinya Kongpetch, Watcharin Loilome, Jarin Chindaprasirt, Attapol Titapun, Nisana Namwat, Narong Khuntikeo, Apinya Jusakul   +10 more
doaj   +1 more source

Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy

Heliyon, 2023
Background: Nutritional status is one of the important factors determining the short- and long-term outcomes of surgery in cancer. This study aimed to assess the prognostic role of preoperative controlling nutritional status (CONUT) score in intrahepatic
Attapol Titapun, Aumkhae Sookprasert, Yanin Sripanuskul, Piyakarn Watcharenwong, Watcharin Loilome, Prin Twinprai, Tharathip Srisuk, Piya Prajumwongs, Jarin Chindaprasirt   +8 more
doaj   +1 more source

Establishment of a Potential Serum Biomarker Panel for the Diagnosis and Prognosis of Cholangiocarcinoma Using Decision Tree Algorithms

Diagnostics, 2021
Potential biomarkers which include S100 calcium binding protein A9 (S100A9), mucin 5AC (MUC5AC), transforming growth factor β1 (TGF-β1), and angiopoietin-2 have previously been shown to be effective for cholangiocarcinoma (CCA) diagnosis.
Phongsaran Kimawaha, Apinya Jusakul, Prem Junsawang, Raynoo Thanan, Attapol Titapun, Narong Khuntikeo, Anchalee Techasen   +6 more
doaj   +1 more source

Efficacy and Safety of External-beam Radiation Therapy for Unresectable Primary or Local Recurrent Cholangiocarcinoma [PDF]

, 2022
Background/Aim: Treatment options for unresectable cholangiocarcinoma are limited. The aim of the study was to evaluate the clinical outcomes of definitive external-beam radiation therapy (EBRT) for patients with unresectable cholangiocarcinoma. Patients
MATSUO, YUKINORI, UZA, NORIMITSU, MURAKAMI, TAKASHI, FUKUDA, AKIHISA, TAURA, KOJIRO, SHIOKAWA, MASAHIRO, MIZOWAKI, TAKASHI, HATANO, ETSURO, AIZAWA, RIHITO, SENO, HIROSHI, KANAI, MASASHI, HANAZAWA, HIDEKI, MUTO, MANABU   +12 more
core   +1 more source

Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma

Frontiers in Public Health, 2022
Gemcitabine and cisplatin serve as appropriate treatments for patients with cholangiocarcinoma (CCA). Our previous study using histoculture drug response assay (HDRA), demonstrated individual response patterns to gemcitabine and cisplatin.
Manida Suksawat, Manida Suksawat, Manida Suksawat, Jutarop Phetcharaburanin, Jutarop Phetcharaburanin, Jutarop Phetcharaburanin, Jutarop Phetcharaburanin, Poramate Klanrit, Poramate Klanrit, Poramate Klanrit, Nisana Namwat, Nisana Namwat, Nisana Namwat, Narong Khuntikeo, Narong Khuntikeo, Narong Khuntikeo, Attapon Titapun, Attapon Titapun, Attapon Titapun, Apiwat Jarearnrat, Apiwat Jarearnrat, Apiwat Jarearnrat, Vanlakhone Vilayhong, Vanlakhone Vilayhong, Vanlakhone Vilayhong, Prakasit Sa-ngiamwibool, Prakasit Sa-ngiamwibool, Prakasit Sa-ngiamwibool, Anchalee Techasen, Anchalee Techasen, Anchalee Techasen, Arporn Wangwiwatsin, Arporn Wangwiwatsin, Arporn Wangwiwatsin, Arporn Wangwiwatsin, Panupong Mahalapbutr, Panupong Mahalapbutr, Jia V. Li, Watcharin Loilome, Watcharin Loilome, Watcharin Loilome, Watcharin Loilome   +41 more
doaj   +1 more source